ArticleComputational and structural biotechnology journal2026
A Co-attention Mechanism of Jointly Capturing Sequence and Structure Features for Signal Peptide Prediction.
Article in Computational and structural biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Signal peptides are short amino acid sequences at the N-terminus of proteins that serve as subcellular localization signals, directing proteins to specific compartments such as mitochondria, chloroplasts, or the secretory pathway. Although many recent predictors based on protein language models have achieved strong performance, most of them rely primarily on sequence information and do not explicitly incorporate structural cues. Here, we propose Signal-3L 4.0, a dual-path encoder framework that combines pretrained protein representations with task-specific sequence and structural modeling for signal peptide prediction, and the 2 modalities are fused via a VisualBERT-style co-attention module. To alleviate the impact of the long-tail distribution across organism groups and signal peptide types, we further employ a class-balanced label-distribution-aware margin loss. Benchmark results show that Signal-3L 4.0 achieves improved signal peptide classification performance and competitive or better cleavage-site prediction performance compared with SignalP 6.0, with particularly superior performance in several low-resource or challenging settings. Signal-3L 4.0 is freely available for academic use as a web server at http://www.csbio.sjtu.edu.cn/bioinf/Signal-3L/ and as open-source code at https://github.com/chandlevier/Signal-3L-4.0.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.